Prospective and multicenter non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with impingement syndrom in the hip.~Safety: 24-month post treatment follow up period by measuring the number of adverse drug reactions/serious adverse drug reactions.~Efficacy: 24-month post treatment follow up period using iHOT 33 and EuroQuol-5D-5L.
Non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with full thickness cartilage defects in the hip.